Search Results
Found 1 results
510(k) Data Aggregation
(60 days)
The BioStrep® A is intended for use as an in vitro diagnostic product for the qualitative detection of group A streptococcal antigen directly from throat swab specimens. The test is intended for use in the physician's offices, hospitals, and clinical laboratories as an aid in the clinical diagnosis of group A streptococcal infection.
Not Found
The provided text is a 510(k) clearance letter from the FDA for a device called BioStrep® A. While it confirms the device's substantial equivalence and outlines regulatory guidelines, it does not contain any information regarding specific acceptance criteria, study details, or performance metrics for the device. Therefore, I cannot generate the requested information based on the given input.
The document states:
- The device is a "BioStrep® A" intended for the "qualitative detection of group A streptococcal antigen directly from throat swab specimens."
- It's for "in vitro diagnostic product" use in "physician's offices, hospitals, and clinical laboratories as an aid in the clinical diagnosis of group A streptococcal infection."
- It refers to a "legally marketed predicate device" for substantial equivalence but does not provide details about that predicate's performance or the specific study comparing the BioStrep® A to it.
To answer your request, I would need a document that describes the clinical performance study, including acceptance criteria (e.g., sensitivity, specificity thresholds), the results of that study, and details about the data collection and analysis.
Ask a specific question about this device
Page 1 of 1